Page last updated: 2024-08-23

nimustine and Invasiveness, Neoplasm

nimustine has been researched along with Invasiveness, Neoplasm in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akiyama, S; Fukushige, T; Gunshin, K; Ikeda, R; Kanekura, T; Kawai, K; Matsushita, S; Okumura, H; Tajitsu, Y; Takeda, Y; Ushiyama, M; Yamada, K	1
Hamano, K; Hojo, K; Kato, K; Kimura, K; Nakajima, A; Ohkawa, T; Soma, T; Tani, C; Tsuchiya, S; Yasutomi, M	1
Ashihara, K; Kimura, S; Kobayashi, Y; Kondo, M; Kuritsuka, H; Maruo, N; Ozawa, M; Sawada, M; Setoguchi, J; Wada, K	1

Trials

1 trial(s) available for nimustine and Invasiveness, Neoplasm

Article	Year
[Comparison of surgical therapy and combined irradiation in rectal cancer--second report. Effect of irradiation and ACNU on the tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Nimustine; Preoperative Care; Radiotherapy Dosage; Rectal Neoplasms; Rectum	1992

Article

Year

[Comparison of surgical therapy and combined irradiation in rectal cancer--second report. Effect of irradiation and ACNU on the tumor].

Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:7

Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Nimustine; Preoperative Care; Radiotherapy Dosage; Rectal Neoplasms; Rectum

1992

Other Studies

2 other study(ies) available for nimustine and Invasiveness, Neoplasm

Article	Year
p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells. Journal of dermatological science, 2012, Volume: 68, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nimustine; Prognosis; Ribonucleotide Reductases; RNA Interference; Skin Neoplasms; Transfection; Vincristine; Young Adult	2012
[Successful bronchial arterial infusion (BAI) of ACNU in the treatment of pulmonary infiltration of acute non-lymphocytic leukemia (ANLL) cells]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:11 Topics: Adult; Blood Cell Count; Bone Marrow Cells; Bronchial Arteries; Combined Modality Therapy; Humans; Infusions, Intra-Arterial; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasm Invasiveness; Nimustine	1990

Article

Year

p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.

Journal of dermatological science, 2012, Volume: 68, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nimustine; Prognosis; Ribonucleotide Reductases; RNA Interference; Skin Neoplasms; Transfection; Vincristine; Young Adult

2012

[Successful bronchial arterial infusion (BAI) of ACNU in the treatment of pulmonary infiltration of acute non-lymphocytic leukemia (ANLL) cells].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:11

Topics: Adult; Blood Cell Count; Bone Marrow Cells; Bronchial Arteries; Combined Modality Therapy; Humans; Infusions, Intra-Arterial; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasm Invasiveness; Nimustine

1990